It has been reported that there is an increased B cell response to IL-6 in lupus patients (Kitani et al., 1992), and the inhibition of IL-6 levels in identified lupus patients helps to restore the balance of these naive B cells and T cells (Shirota et al., 2013). The gene discussed is IL6; the disease is systemic lupus erythematosus.